ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 124 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $51,383 | -63.6% | 25,312 | -58.7% | 0.00% | – |
Q2 2023 | $140,997 | -87.4% | 61,303 | -83.4% | 0.00% | -100.0% |
Q1 2023 | $1,120,424 | +2283.9% | 369,777 | +1412.9% | 0.00% | – |
Q3 2022 | $47,000 | -86.8% | 24,442 | -79.5% | 0.00% | -100.0% |
Q1 2022 | $355,000 | -89.7% | 119,081 | -86.6% | 0.00% | -85.7% |
Q4 2021 | $3,445,000 | +10.0% | 885,537 | +21.3% | 0.01% | 0.0% |
Q3 2021 | $3,133,000 | +307.4% | 730,298 | +187.7% | 0.01% | +250.0% |
Q2 2021 | $769,000 | -70.0% | 253,823 | -67.0% | 0.00% | -71.4% |
Q1 2021 | $2,561,000 | +396.3% | 769,051 | +171.3% | 0.01% | +133.3% |
Q2 2020 | $516,000 | +140.0% | 283,507 | +33.5% | 0.00% | +50.0% |
Q1 2020 | $215,000 | -15.0% | 212,400 | +133.8% | 0.00% | +100.0% |
Q4 2019 | $253,000 | +644.1% | 90,864 | +302.1% | 0.00% | – |
Q3 2019 | $34,000 | -81.4% | 22,599 | -74.4% | 0.00% | -100.0% |
Q2 2019 | $183,000 | -19.4% | 88,106 | +39.1% | 0.00% | 0.0% |
Q1 2019 | $227,000 | +13.5% | 63,334 | +21.0% | 0.00% | 0.0% |
Q4 2018 | $200,000 | -12.7% | 52,344 | +116.2% | 0.00% | 0.0% |
Q3 2018 | $229,000 | -56.9% | 24,211 | -66.7% | 0.00% | -50.0% |
Q2 2018 | $531,000 | +147.0% | 72,714 | +70.4% | 0.00% | +100.0% |
Q4 2017 | $215,000 | – | 42,665 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 260,000 | $866,000 | 0.34% |
RTW INVESTMENTS, LP | 5,978,355 | $19,908,000 | 0.31% |
GSA CAPITAL PARTNERS LLP | 309,839 | $1,032,000 | 0.17% |
QCM Cayman, Ltd. | 12,728 | $42,000 | 0.13% |
COWEN AND COMPANY, LLC | 486,717 | $1,621,000 | 0.11% |
Hudson Bay Capital Management LP | 1,400,000 | $4,662,000 | 0.06% |
Kerrisdale Advisers, LLC | 208,150 | $693,000 | 0.05% |
Secure Asset Management, LLC | 10,000 | $33,000 | 0.02% |
PDT Partners, LLC | 72,500 | $241,000 | 0.02% |
Point72 Asset Management, L.P. | 1,037,700 | $3,456,000 | 0.02% |